Viewing Study NCT04919369


Ignite Creation Date: 2025-12-24 @ 10:50 PM
Ignite Modification Date: 2026-01-01 @ 4:29 AM
Study NCT ID: NCT04919369
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-11-10
First Post: 2021-06-03
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: All-Trans Retinoic Acid (ATRA) and Atezolizumab for the Treatment of Recurrent or Metastatic Non-Small Cell Lung Cancer
Sponsor: Dwight Owen
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module